Manager × security

Knott David M Jr VRNA holdings history

VERONA PHARMA PLC - ADR · CUSIP 925050106 · CIK 1892770

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2025-09-30, Knott David M Jr reported 38.35K VRNA (shares), valued at $4.09M, or 1.71% of its reported non-derivative portfolio. Filed 2025-11-12.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.71%
Shares
38.35K
38,355
Reported value
$4.09M
USD

Shares decreased 30.26%; reported value decreased 21.32%, and weight changed -0.65 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 2026Not reportedNot reported—
Q1 2026Not reportedNot reported—
Q4 2025Not reportedNot reported—
Q3 20251.71%38,355SEC filing ↗Filed Nov 12, 2025
Q2 20252.36%55,000SEC filing ↗Filed Aug 11, 2025
Q1 20252.64%88,000SEC filing ↗Filed May 12, 2025
Q4 20242.68%159,300SEC filing ↗Filed Feb 12, 2025
Q3 20241.82%180,000SEC filing ↗Filed Nov 13, 2024
Q2 20241.17%203,000SEC filing ↗Filed Aug 12, 2024
Q1 20240.65%115,000SEC filing ↗Filed May 14, 2024
Q4 20230.25%32,672SEC filing ↗Filed Feb 13, 2024
Q3 2023Not reportedNot reported—

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 2023Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q4 20230.25%32,672$650.00KA comparable prior-quarter record is unavailable; changes are not inferred.SEC filing ↗
Filed Feb 13, 2024
Q1 20240.65%115,000$1.85MShares increased 251.98%; reported value increased 184.62%, and weight changed +0.40 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2024
Q2 20241.17%203,000$2.94MShares increased 76.52%; reported value increased 58.65%, and weight changed +0.52 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 12, 2024
Q3 20241.82%180,000$5.18MShares decreased 11.33%; reported value increased 76.46%, and weight changed +0.65 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2024
Q4 20242.68%159,300$7.40MShares decreased 11.50%; reported value increased 42.84%, and weight changed +0.86 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 12, 2025
Q1 20252.64%88,000$5.59MShares decreased 44.76%; reported value decreased 24.48%, and weight changed -0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 12, 2025
Q2 20252.36%55,000$5.20MShares decreased 37.50%; reported value decreased 6.89%, and weight changed -0.28 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2025
Q3 20251.71%38,355$4.09MShares decreased 30.26%; reported value decreased 21.32%, and weight changed -0.65 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2025
Q4 2025Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q1 2026Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q2 2026Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Knott David M Jr · VERONA PHARMA PLC - ADR

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1892770","quarter":"2026Q2","cusip":"925050106"}

get_institutional_manager_history
{"cik":"1892770","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.